Aeon, a Zurich health tech startup, extended its seed funding round and acquired Aware Health’s blood diagnostics assets
Acquisition Provisional 88% confidence first seen
Aeon closed an extended seed round and acquired Aware Health’s core blood diagnostics assets, including its technology and team. The company said it will integrate the assets into its AI-driven whole-body check-ups, using the regulated diagnostics stack and blood-draw network to support its European roadmap and recurring data collection.
The deal
Aeon more than USD 14 million (about EUR 12 million) Seed · announced 14 Sep 2026
Deal terms as reported in the coverage below.